MedPath

CIFASD 5 tDCS and Cognitive Training

Not Applicable
Recruiting
Conditions
Fetal Alcohol Spectrum Disorders
Interventions
Behavioral: Cognitive Training
Device: Active tDCS
Device: Sham tDCS
Registration Number
NCT05456321
Lead Sponsor
University of Minnesota
Brief Summary

This is a randomized placebo-controlled trial of cognitive training with transcranial direct current stimulation (tDCS) for children and adolescents (ages 8 - 17 years) with prenatal alcohol exposure (PAE).

Detailed Description

Prenatal alcohol exposure (PAE) has profound detrimental effects on brain development and, as a result, has permanent consequences for cognition, learning, and behavior. Individuals with Fetal Alcohol Spectrum Disorders (FASD) commonly have a range of neurocognitive impairments that directly lead to practical problems with learning, attention, working memory, task planning/execution, and decision making, among other areas of functioning. Despite the profound public health burden posed by FASD, there have been very few treatment studies in this population. This study will examine the effects of a cognitive remediation training augmented with transcranial direct current stimulation (tDCS) in children and adolescents with PAE. The study involves a baseline visit with cognitive testing, 5 sessions of tDCS (including the baseline visit) with active and sham arms, a 6th visit for cognitive testing.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Documented heavy prenatal alcohol exposure (self-report, social service records, or adoption records) and meeting criteria for an associated FASD diagnosis (FAS, partial FAS, or ARND).
  • An available parent or legal guardian capable of giving informed consent
Exclusion Criteria
  • Substance abuse in the participant
  • Neurological condition or other developmental disorder
  • Serious psychiatric disorder known to affect brain functioning and cognitive performance Birthweight < 1500 grams
  • MRI contraindication
  • tDCS contraindication

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cognitive Training and Sham tDCSCognitive Training5 sessions of computerized executive functioning training - plus sham tDCS (also 5 sessions).
Cognitive Training and Active tDCSCognitive Training5 sessions of computerized executive functioning training - plus active tDCS (also 5 sessions).
Cognitive Training and Sham tDCSSham tDCS5 sessions of computerized executive functioning training - plus sham tDCS (also 5 sessions).
Cognitive Training and Active tDCSActive tDCS5 sessions of computerized executive functioning training - plus active tDCS (also 5 sessions).
Primary Outcome Measures
NameTimeMethod
Change in Continuous Performance Test performanceAfter each study visit (approx. bi-weekly) for the duration of the study (10 visits, approx. 5 weeks)

Change in Continuous Performance Test performance

Change in Delis-Kaplan Executive Function System Color Word Interference performanceVisit 1 and Visit 5 (approx. 3 weeks apart)

Change in Delis-Kaplan Executive Function System - Color Word Interference performance

Change in Wechsler Digit Span performanceVisit 1 and Visit 5 (approx. 3 weeks apart)

Change in Wechsler Intelligence Scale for Children or Wechsler Adult Intelligence Digit Span performance

Change in Wechsler Picture Span performanceVisit 1 and Visit 5 (approx. 3 weeks apart)

Change in Wechsler Intelligence Scale for Children or Wechsler Adult Intelligence Scale Picture Span performance

Change in Delis-Kaplan Executive Function System -Trail Making performanceVisit 1 and Visit 5 (approx. 3 weeks apart)

Change in Delis-Kaplan Executive Function System - Trail Making performance

Secondary Outcome Measures
NameTimeMethod
Change in Oral Word Reading Fluency performanceVisit 1 and Visit 5 (approx. 3 weeks apart)

Change in Oral Word Reading Fluency performance

Change in Math Fluency performanceVisit 1 and Visit 5 (approx. 3 weeks apart)

Change in Mathematics Fluency performance

Trial Locations

Locations (1)

University of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath